Akso Health (AHG) Receivables (2018 - 2026)

Akso Health (AHG) has reported Receivables for 9 consecutive years, with $193.8 million the latest figure, recorded in Q1 2026.

• Quarterly Receivables fell 8.26% year-over-year to $193.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $193.8 million (down 8.26% YoY) and the FY2026 annual result came in at $193.8 million, down 9.67% from the prior year.
• Receivables advanced to $193.8 million in Q1 2026 per AHG's latest filing, from $10.8 million in the prior quarter.
• Over the last five years, Receivables for AHG reached as high as $211.3 million in Q1 2025 and fell as low as $7.8 million in Q3 2023.
• A 5-year average of $60.8 million and a median of $33.4 million in 2022 frame the typical range for Receivables.
• Annual changes were most pronounced in 2022 — Receivables slumped 100.0% — and 2025, when it surged 2618.63%.
• Year by year, Receivables stood at $33.4 million in 2022, then slumped by 76.7% to $7.8 million in 2023, then rose by 4.61% to $8.1 million in 2024, then surged by 33.36% to $10.8 million in 2025, then surged by 1687.9% to $193.8 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $193.8 million, $10.8 million, and $211.3 million for Q1 2026, Q3 2025, and Q1 2025 respectively.